By EARL D. FOWLKES Jr.
Contributor 

To save lives, clinical trials need diversity

Commentary

 

Last updated 2/18/2021 at 11:39am



I’ve spent my career fighting for vulnerable patients, especially people of color. So I was ecstatic to hear about a new initiative from dozens of biotech companies.

These firms pledged to enroll more people of color in “clinical trials” — years-long tests that show whether experimental drugs are safe and effective. Boosting diversity will tangibly improve the health of minority Americans.

White Americans are drastically overrepresented in clinical trials. Non-Hispanic whites account for 60% of the U.S. population, but roughly 86% of clinical trial participants. By contrast, Black A...



For access to this article please sign in or subscribe.

 

Reader Comments(0)

 
 

Powered by ROAR Online Publication Software from Lions Light Corporation
© Copyright 2021

Rendered 10/22/2021 12:45